These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2200108)

  • 1. [Immunosuppressive therapy of multiple sclerosis using cyclosporin A and azathioprine. Long-term effects, risks, proton spin tomography and immunological findings].
    Kappos L
    Schriftenr Neurol; 1990; 32():1-200. PubMed ID: 2200108
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study.
    Kappos L; Patzold U; Dommasch D; Poser S; Haas J; Krauseneck P; Malin JP; Fierz W; Graffenried BU; Gugerli US
    Ann Neurol; 1988 Jan; 23(1):56-63. PubMed ID: 3278672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and tolerance of cyclosporin A in the treatment of multiple sclerosis].
    Schluep M; Steck AJ; Despland PA; Regli F; Ochsner F; Berrut E; Gauthier G
    Schweiz Rundsch Med Prax; 1991 Jun; 80(24):670-2. PubMed ID: 2068440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine versus azathioprine in the treatment of multiple sclerosis: 12-month clinical and immunological evaluation.
    Steck AJ; Regli F; Ochsner F; Gauthier G
    Eur Neurol; 1990; 30(4):224-8. PubMed ID: 2209678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis.
    Kappos L; Städt D; Ratzka M; Keil W; Schneiderbanger-Grygier S; Heitzer T; Poser S; Nadjmi M
    Neuroradiology; 1988; 30(4):299-302. PubMed ID: 3050587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term therapeutic trials and multiple sclerosis: a wager?].
    Confavreux C
    Rev Neurol (Paris); 1983; 139(6-7):431-7. PubMed ID: 6412341
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current studies of the effects of immunosuppressive agents on multiple sclerosis].
    Minderhoud JM
    Ned Tijdschr Geneeskd; 1989 Jan; 133(3):99-100. PubMed ID: 2646546
    [No Abstract]   [Full Text] [Related]  

  • 8. Azathioprine in multiple sclerosis: the cons.
    Silberberg DH
    Neurology; 1988 Jul; 38(7 Suppl 2):24-7. PubMed ID: 3290710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic trials for multiple sclerosis.
    McKhann GM
    Ann Neurol; 1990 Jun; 27(6):589-90. PubMed ID: 2193612
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multiple sclerosis--current status of therapy].
    Reichel D; Kölmel HW
    Z Arztl Fortbild (Jena); 1995 May; 89(2):151-8. PubMed ID: 7610682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Side effects of azathioprine (Imurel). Apropos of 313 patients treated for multiple sclerosis. Review of the literature].
    Ventre JJ; Guillot M; Confavreux C; Evreux JC; Aimard G
    Therapie; 1985; 40(3):195-202. PubMed ID: 4012666
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunosuppressive treatment in multiple sclerosis].
    Minderhoud JM; Prange AJ; Luijckx GJ
    Ned Tijdschr Geneeskd; 1987 May; 131(22):966-7. PubMed ID: 3299110
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine and multiple sclerosis: the cons.
    Rudge P
    Neurology; 1988 Jul; 38(7 Suppl 2):29-30. PubMed ID: 3290712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic options in multiple sclerosis: present and future.
    Steck AJ; Burger D; Bourdenet S; Regli F; Ochsner F; Berrut E; Gauthier G
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(2):135-6. PubMed ID: 1710387
    [No Abstract]   [Full Text] [Related]  

  • 16. Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.
    Frohman EM; Havrdova E; Lublin F; Barkhof F; Achiron A; Sharief MK; Stuve O; Racke MK; Steinman L; Weiner H; Olek M; Zivadinov R; Corboy J; Raine C; Cutter G; Richert J; Filippi M
    Arch Neurol; 2006 Apr; 63(4):614-9. PubMed ID: 16606781
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-term immunosuppression in multiple sclerosis: evaluation of treatments begun before 1972].
    Sabouraud O; Oger J; Darcel F; Madigand M; Merienne M
    Rev Neurol (Paris); 1984; 140(2):125-30. PubMed ID: 6710012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cyclosporin versus azathioprine].
    Manganoni AM; Gavazzoni R; Calzavara Pinton PG; Graifemberghi S; Manganoni A; Scolari F; Sandrini S
    G Ital Dermatol Venereol; 1986; 121(6):453-5. PubMed ID: 2951323
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prolonged treatment of multiple sclerosis with average doses of azathioprine. An evaluation of 15 years' experience].
    Lhermitte F; Marteau R; Roullet E; de Saxcé H; Loridan M
    Rev Neurol (Paris); 1984; 140(10):553-8. PubMed ID: 6438761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant glomerulonephritis under conventional and cyclosporin A immunosuppression.
    Yussim A; Ben-Bassat M; Shapira Z; Shmueli D; Shaharabani E; Lustig S; Nakache R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2119-20. PubMed ID: 2652684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.